Home › Funds › Ikarian Capital, LLC › SLS
Ikarian Capital, LLC position in SLS
SELLAS LIFE SCIENCES GROUP INC COM NEW · Health Care
Ikarian Capital, LLC reported holding 354,700 shares of SLS (SELLAS LIFE SCIENCES GROUP INC COM NEW) in its Q2 2026 13F filing — a position valued at US$5.2M, representing 0.84% of its reported portfolio and ranking #41 among its reported holdings. Ikarian Capital, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Ikarian Capital, LLC's SLS position evolved
Ikarian Capital, LLC first disclosed a stake in SLS in Q2 2026 at 354,700 shares (US$5.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 354.70K | $5.24M | New |
About SLS and 13F data
SLS (SELLAS LIFE SCIENCES GROUP INC COM NEW) is a Health Care company. 129 other funds we track also report a position in SLS — the largest reported positions include DAGCO, INC. (US$18.2M), Sio Capital Management, LLC (US$18.2M), Anson Funds Management LP (US$11.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SLS
- DAGCO, INC. 1.23M sh · $18.19M · Q2 2026
- Sio Capital Management, LLC 1.23M sh · $18.17M · Q2 2026
- Anson Funds Management LP 800.00K sh · $11.81M · Q2 2026
- Opus Capital Group, LLC 385.60K sh · $5.69M · Q2 2026
- Rosalind Advisors, Inc. 568.70K sh · $2.30M · Q2 2026
- FULCRUM WEALTH ADVISORS, LLC 85.45K sh · $1.05M · Q3 2026
- VISION FINANCIAL MARKETS LLC 57.00K sh · $701.67K · Q3 2026
- INSTRUMENTAL WEALTH, LLC 44.91K sh · $662.93K · Q2 2026
More on Ikarian Capital, LLC
FAQ
How long has Ikarian Capital, LLC held SLS?
Ikarian Capital, LLC has disclosed SLS holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Ikarian Capital, LLC's current position in SLS?
As of Q2 2026, Ikarian Capital, LLC holds 354.70K shares of SLS (SELLAS LIFE SCIENCES GROUP INC COM NEW), valued at $5.24M, representing 0.84% of its reported portfolio and ranking #41.
Has Ikarian Capital, LLC been buying or selling SLS?
In the latest 13F filing (Q2 2026), Ikarian Capital, LLC newly opened its position in SLS.
Which other funds hold SLS?
Other major institutional holders of SLS include DAGCO, INC., Sio Capital Management, LLC, Anson Funds Management LP, among 129 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.